- Home
- NUVB vs AVNS Comparison
NUVB vs AVNS Comparison
Compare NUVB & AVNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NUVB
- AVNS
- Stock Information
- Founded
- NUVB 2018
- AVNS 2014
- Country
- NUVB United States
- AVNS United States
- Employees
- NUVB N/A
- AVNS N/A
- Industry
- NUVB Biotechnology: Pharmaceutical Preparations
- AVNS Industrial Specialties
- Sector
- NUVB Health Care
- AVNS Health Care
- Exchange
- NUVB Nasdaq
- AVNS Nasdaq
- Market Cap
- NUVB 679.9M
- AVNS 641.7M
- IPO Year
- NUVB N/A
- AVNS N/A
- Fundamental
- Price
- NUVB $2.10
- AVNS $12.64
- Analyst Decision
- NUVB Strong Buy
- AVNS Hold
- Analyst Count
- NUVB 5
- AVNS 1
- Target Price
- NUVB $8.20
- AVNS N/A
- AVG Volume (30 Days)
- NUVB 3.2M
- AVNS 504.3K
- Earning Date
- NUVB 05-07-2025
- AVNS 05-06-2025
- Dividend Yield
- NUVB N/A
- AVNS N/A
- EPS Growth
- NUVB N/A
- AVNS N/A
- EPS
- NUVB N/A
- AVNS N/A
- Revenue
- NUVB $10,957,000.00
- AVNS $689,200,000.00
- Revenue This Year
- NUVB $75.73
- AVNS N/A
- Revenue Next Year
- NUVB $440.21
- AVNS $3.36
- P/E Ratio
- NUVB N/A
- AVNS N/A
- Revenue Growth
- NUVB N/A
- AVNS 1.34
- 52 Week Low
- NUVB $1.54
- AVNS $11.84
- 52 Week High
- NUVB $3.97
- AVNS $25.36
- Technical
- Relative Strength Index (RSI)
- NUVB 50.80
- AVNS 46.27
- Support Level
- NUVB $1.98
- AVNS $12.35
- Resistance Level
- NUVB $2.30
- AVNS $13.31
- Average True Range (ATR)
- NUVB 0.16
- AVNS 0.44
- MACD
- NUVB -0.01
- AVNS 0.12
- Stochastic Oscillator
- NUVB 21.43
- AVNS 50.92
About NUVB Nuvation Bio Inc.
Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. The company's clinical-stage product candidate is NUV-868, a BD2-selective oral small molecule BET inhibitor. NUV-868 inhibits the protein BRD4, a key member of the BET family that epigenetically regulates a number of important proteins that control tumor growth and differentiation, including oncogenes such as c-myc. Notably, BET proteins have critical biological functions and are found to be altered in many human cancers. It is also developing its proprietary, small molecule Drug-Drug Conjugate (DDC) platform, a novel therapeutic approach within the drug-conjugate class of anti-cancer therapies with parallels to Antibody-Drug Conjugates (ADCs).
About AVNS Avanos Medical Inc.
Avanos Medical Inc is a United States-based company that develops and sells medical devices and related services globally. Its operating and reportable segment provides medical device products to healthcare providers and patients. The company has now changed two franchises: has combined Chronic Care and Pain Management franchises into a single commercial organization focused on the Digestive Health and Pain Management and Recovery product categories that generate its revenue from its Chronic Care franchise and in North America.